A Novel Locomotion-Based Validation Assay for Candidate Drugs Using Drosophila DYT1 Disease Model

doi 10.21236/ada608248
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Defense Technical Information Center

Related search

Recent Developments in Using Drosophila as a Model for Human Genetic Disease

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Drosophila as a Model for Human Neurodegenerative Disease

Annual Review of Genetics
Genetics
2005English

Novel Candidate Blood-Based Transcriptional Biomarkers of Machado-Joseph Disease

Movement Disorders
Neurology
2015English

A Subset of Interneurons Required for Drosophila Larval Locomotion

Molecular and Cellular Neurosciences
Molecular NeuroscienceMolecular BiologyCell BiologyCellular
2016English

Drosophila Melanogaster as a Model Organism for Alzheimer’s Disease

Molecular Neurodegeneration
Molecular NeuroscienceNeurologyMolecular BiologyCellular
2013English

A Novel High Throughput High Content Analysis Assay for Intermediate Filament Perturbing Drugs

Journal of Integrated OMICS
BiochemistryGeneticsMolecular Biology
2014English

A Locomotor Assay Reveals Deficits in Heterozygous Parkinson’s Disease Model and Proprioceptive Mutants in Adult Drosophila

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

LB815 Validation of EpiScreen TM as a Predictive in Vitro Cell-Based Assay for Screening Dermatological Drugs by High Content Approaches

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2016English

Searching for Novel Biomarkers Using a Mouse Model of CLN3-Batten Disease

PLoS ONE
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy